BAFF (BLyS, TALL-1, THANK, zTNF4) is a member of the TNF superfamily that specifically regulates B lymphocyte proliferation and survival. Mice transgenic (Tg) for BAFF develop an autoimmune condition similar to systemic lupus erythematosus. We now demonstrate that BAFF Tg mice, as they age, develop a secondary pathology reminiscent of Sjögren’s syndrome (SS), which is manifested by severe sialadenitis, decreased saliva production, and destruction of submaxillary glands. In humans, SS also correlates with elevated levels of circulating BAFF, as well as a dramatic upregulation of BAFF expression in inflamed salivary glands. A likely explanation for disease in BAFF Tg mice is excessive survival signals to autoreactive B cells, possibly as they pass through a critical tolerance checkpoint while maturing in the spleen. The marginal zone (MZ) B cell compartment, one of the enlarged B cell subsets in the spleen of BAFF Tg mice, is a potential reservoir of autoreactive B cells. Interestingly, B cells with an MZ-like phenotype infiltrate the salivary glands of BAFF Tg mice, suggesting that cells of this compartment potentially participate in tissue damage in SS and possibly other autoimmune diseases. We conclude that altered B cell differentiation and tolerance induced by excess BAFF may be central to SS pathogenesis.
Joanna Groom, Susan L. Kalled, Anne H. Cutler, Carl Olson, Stephen A. Woodcock, Pascal Schneider, Jurg Tschopp, Teresa G. Cachero, Marcel Batten, Julie Wheway, Davide Mauri, Dana Cavill, Tom P. Gordon, Charles R. Mackay, Fabienne Mackay
Title and authors | Publication | Year |
---|---|---|
Carboxyamidotriazole Regulates the Function of Salivary Gland Epithelial Cells and B Cells to Alleviate Experimental Sjögren′s Disease in Mice
Zhang X, Liu J, Yang M, Li J, Zhu L |
International Journal of Medical Sciences | 2025 |
Efficacy of BAFF inhibition and B-cell depletion in non-obese diabetic mice as a spontaneous model for Sjögren's syndrome
Renaud Felten, Anne-Perrine Foray, Pascal Schneider, Cindy Marquet, Coralie Pecquet, Fanny Monneaux, Hélène Dumortier, Jean Sibilia, Fabrice Valette, Lucienne Chatenoud, Jacques-Eric Gottenberg |
RMD open | 2024 |
B cell focused transient immune suppression protocol for efficient AAV readministration to the liver
Rana J, Herzog RW, Muñoz-Melero M, Yamada K, Kumar SR, Lam AK, Markusic DM, Duan D, Terhorst C, Byrne BJ, Corti M, Biswas M |
2024 | |
B-Cell Activation Biomarkers in Salivary Glands Are Related to Lymphomagenesis in Primary Sjögren’s Disease: A Pilot Monocentric Exploratory Study
Bruno D, Tolusso B, Lugli G, Di Mario C, Petricca L, Perniola S, Bui L, Benvenuto R, Ferraccioli G, Alivernini S, Gremese E |
International journal of molecular sciences | 2024 |
Iguratimod suppresses plasma cell differentiation and ameliorates experimental Sjögren's syndrome in mice by promoting TEC kinase degradation.
Yang YQ, Liu YJ, Qiao WX, Jin W, Zhu SW, Yan YX, Luo Q, Xu Q |
Acta Pharmacologica Sinica | 2024 |
Splenic marginal zone B cells restrict Mycobacterium tuberculosis infection by shaping the cytokine pattern and cell-mediated immunity.
Tsai CY, Oo M, Peh JH, Yeo BCM, Aptekmann A, Lee B, Liu JJJ, Tsao WS, Dick T, Fink K, Gengenbacher M |
Cell Reports | 2024 |
The role of cytokines from salivary gland epithelial cells in the immunopathology of Sjögren’s syndrome
Dong Y, Wang T, Wu H |
Frontiers in Immunology | 2024 |
An Overview of the Dry Eye Disease in Sjögren’s Syndrome Using Our Current Molecular Understanding
Wu KY, Kulbay M, Tanasescu C, Jiao B, Nguyen BH, Tran SD |
International journal of molecular sciences | 2023 |
Association of Serum BAFF Levels with Cardiovascular Events in ST-Segment Elevation Myocardial Infarction
Wang Z, Wang Y, Cui Y, Chen Z, Yi L, Zhu Z, Ni J, Du R, Wang X, Zhu J, Ding F, Quan W, Zhang R, Hu J, Yan X |
Journal of Clinical Medicine | 2023 |
Mitochondria as disease-relevant organelles in rheumatoid arthritis.
Weyand CM, Wu B, Huang T, Hu Z, Goronzy JJ |
Clinical & Experimental Immunology | 2023 |
Targeting alarmin release reverses Sjogren's syndrome phenotype by revitalizing Ca2+ signalling
Sun Y, Nascimento Da Conceicao V, Chauhan A, Sukumaran P, Chauhan P, Ambrus JL, Vissink A, Kroese FG, Muniswamy M, Mishra BB, Singh BB |
Clinical and Translational Medicine | 2023 |
The characteristics of chest HRCT and pulmonary function tests in lung‐onset primary sjogren's syndrome
Dong X, Gao Y, Li M, Wang D, Li J, Zhang Y |
Immunity, Inflammation and Disease | 2023 |
Associations between TNFSF13B polymorphisms and primary Sjögren's syndrome susceptibility in primary Sjögren's syndrome patients: A meta‐analysis
Zheng A, Hu N, Xu J, Yuan Y, Zhang S, Chen W, Bai Y, Sun H |
Immunity, Inflammation and Disease | 2023 |
The role of microRNAs involved in the disorder of blood–brain barrier in the pathogenesis of multiple sclerosis
Emami Nejad A, Mostafavi Zadeh SM, Nickho H, Sadoogh Abbasian A, Forouzan A, Ahmadlou M, Nedaeinia R, Shaverdi S, Manian M |
Frontiers in immunology | 2023 |
Research hotspots and emerging trends in the treatment of Sjogren's syndrome: A bibliometric analysis from 1900 to 2022
Song W, Wang H, Wang X |
Heliyon | 2023 |
Stromal Notch ligands foster lymphopenia-driven functional plasticity and homeostatic proliferation of naïve B cells
Daniela Gómez Atria, Brian T. Gaudette, Jennifer Londregan, Samantha Kelly, Eric Perkey, Anneka Allman, Bhaskar Srivastava, Ute Koch, Freddy Radtke, Burkhard Ludewig, Christian W. Siebel, Russell J.H. Ryan, Tanner F. Robertson, Janis K. Burkhardt, Warren S. Pear, David Allman, Ivan Maillard |
Journal of Clinical Investigation | 2022 |
The Immunogenetics of Dermatologic Diseases
N Rezaei, F Rajabi |
2022 | |
Plasmacytoid dendritic cells promote the pathogenesis of Sjögren's syndrome
J Zhou, X Zhang, Q Yu |
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease | 2022 |
Abnormal Epigenetic Regulations in the Immunocytes of Sjögren’s Syndrome Patients and Therapeutic Potentials
Li P, Han M, Zhao X, Ren G, Mei S, Zhong C |
Cells | 2022 |
Decreased BAFF Receptor Expression and Unaltered B Cell Receptor Signaling in Circulating B Cells from Primary Sjögren's Syndrome Patients at Diagnosis.
Neys SFH, Verstappen GM, Bootsma H, Kroese FGM, Hendriks RW, Corneth OBJ |
International journal of molecular sciences | 2022 |
Current and Innovated Managements for Autoimmune Bullous Skin Disorders: An Overview
Chu KY, Yu HS, Yu S |
Journal of Clinical Medicine | 2022 |
Serum immune modulators associated with immune-related toxicities and efficacy of atezolizumab in patients with non-small cell lung cancer.
Inoue Y, Inui N, Karayama M, Asada K, Matsuura S, Ikeda M, Uto T, Fujii M, Hashimoto D, Matsui T, Matsuda H, Inami N, Toyoshima M, Kaida Y, Yasui H, Hozumi H, Suzuki Y, Furuhashi K, Enomoto N, Fujisawa T, Suda T |
Journal of Cancer Research and Clinical Oncology | 2022 |
Loss of T cell tolerance in the skin following immunopathology is linked to failed restoration of the dermal niche by recruited macrophages.
West HC, Davies J, Henderson S, Adegun OK, Ward S, Ferrer IR, Tye CA, Vallejo AF, Jardine L, Collin M, Polak ME, Bennett CL |
Cell Reports | 2022 |
Kinetics of free and ligand-bound atacicept in human serum
Eslami M, Willen D, Papasouliotis O, Schuepbach-Mallpell S, Willen L, Donzé O, Yalkinoglu Ö, Schneider P |
Frontiers in immunology | 2022 |
Humoral response in Leishmaniasis
Conde L, Maciel G, de Assis GM, Freire-de-Lima L, Nico D, Vale A, Freire-de-Lima CG, Morrot A |
Frontiers in Cellular and Infection Microbiology | 2022 |
Renal Tissue Expression of BAFF and BAFF Receptors Is Associated with Proliferative Lupus Nephritis
Marín-Rosales M, Palafox-Sánchez CA, Franco-Topete RA, Carrillo-Ballesteros FJ, Cruz A, Salazar-Camarena DC, Muñoz-Valle JF, Ramos-Solano F |
Journal of Clinical Medicine | 2022 |
The effects of B‐cell–activating factor on the population size, maturation and function of murine natural killer cells
Quah PS, Sutton V, Whitlock E, Figgett WA, Andrews DM, Fairfax KA, Mackay F |
Immunology and Cell Biology | 2022 |
TLR7 Signaling Drives the Development of Sjögren’s Syndrome
Y Wang, A Roussel-Queval, L Chasson, NH Kazazian, L Marcadet, A Nezos, MH Sieweke, C Mavragani, L Alexopoulou |
Frontiers in immunology | 2021 |
Fecal Microbiota Transplantation Modulates Renal Phenotype in the Humanized Mouse Model of IgA Nephropathy
G Lauriero, L Abbad, M Vacca, G Celano, JM Chemouny, M Calasso, L Berthelot, L Gesualdo, MD Angelis, RC Monteiro |
Frontiers in immunology | 2021 |
B Cell Dysregulation in Common Variable Immunodeficiency Interstitial Lung Disease
EM Matson, ML Abyazi, KA Bell, KM Hayes, PJ Maglione |
Frontiers in immunology | 2021 |
Role of the Innate Immunity Signaling Pathway in the Pathogenesis of Sjögren’s Syndrome
T Shimizu, H Nakamura, A Kawakami |
International journal of molecular sciences | 2021 |
Shared Pathogenetic Features Between Common Variable Immunodeficiency and Sjögren’s Syndrome: Clues for a Personalized Medicine
L Quartuccio, GD Marchi, S Longhino, V Manfrè, MT Rizzo, S Gandolfo, A Tommasini, SD Vita, R Fox |
Frontiers in immunology | 2021 |
Autoimmune B Cell Repertoire in a Mouse Model of Sjögren’s Syndrome
MS Moya, R Gutiérrez-Cózar, J Puñet-Ortiz, ML de la Concepción, J Blanco, J Carrillo, P Engel |
Frontiers in immunology | 2021 |
Mechanisms of Action of the New Antibodies in Use in Multiple Myeloma
A Romano, P Storti, V Marchica, G Scandura, L Notarfranchi, L Craviotto, FD Raimondo, N Giuliani |
Frontiers in Oncology | 2021 |
Genetics and epigenetics in primary Sjögren’s syndrome
J Imgenberg-Kreuz, A Rasmussen, K Sivils, G Nordmark |
Rheumatology | 2021 |
Advances in Pathogenesis of Sjögren’s Syndrome
Y Tian, H Yang, N Liu, Y Li, J Chen, Y Yang |
Journal of Immunology Research | 2021 |
Rituximab Therapy for Primary Sjögren’s Syndrome
YH Chen, XY Wang, X Jin, Z Yang, J Xu |
Frontiers in pharmacology | 2021 |
Effects of Dietary Brown Rice on the Growth Performance, Systemic Oxidative Status, and Splenic Inflammatory Responses of Broiler Chickens under Chronic Heat Stress
F Nanto-Hara, H Ohtsu, M Yamazaki, T Hirakawa, K Sato, H Murakami |
The Journal of Poultry Science | 2021 |
Thymic Epithelial Cell Alterations and Defective Thymopoiesis Lead to Central and Peripheral Tolerance Perturbation in MHCII Deficiency
F Ferrua, I Bortolomai, E Fontana, DD Silvestre, R Rigoni, GE Marcovecchio, E Draghici, F Brambilla, MC Castiello, G Delfanti, D Moshous, C Picard, T Taghon, V Bordon, AS Schulz, C Schuetz, S Giliani, A Soresina, AR Gennery, S Signa, BJ Saldaña, OM Delmonte, LD Notarangelo, CM Roifman, PL Poliani, P Uva, PL Mauri, A Villa, M Bosticardo |
Frontiers in immunology | 2021 |
Systemic and cerebrospinal fluid immune and complement activation in Ugandan children and adolescents with long‐standing nodding syndrome: A case‐control study
R Ogwang, D Muhanguzi, K Mwikali, R Anguzu, J Kubofcik, TB Nutman, M Taylor, CR Newton, A Vincent, AL Conroy, K Marsh, R Idro |
Epilepsia Open | 2021 |
Role of B-Cell Activating Factor (BAFF) in Inflammatory Bowel Disease.
Kumric M, Zivkovic PM, Ticinovic Kurir T, Vrdoljak J, Vilovic M, Martinovic D, Bratanic A, Lizatovic IK, Bozic J |
2021 | |
New developments in Sjogren's syndrome.
Thalayasingam N, Baldwin K, Judd C, Ng WF |
Rheumatology (Oxford, England) | 2021 |
BAFF Attenuates Immunosuppressive Monocytes in the Melanoma Tumor Microenvironment
Liu W, Stachura P, Xu HC, Váraljai R, Shinde P, Ganesh NU, Mack M, Van Lierop A, Huang A, Sundaram B, Lang KS, Picard D, Fischer U, Remke M, Homey B, Roesch A, Häussinger D, Lang PA, Borkhardt A, Pandyra AA |
Cancer research | 2021 |
Sex differences in lymphoid follicles in COPD airways
A Tam, N Tanabe, A Churg, JL Wright, JC Hogg, DD Sin |
Respiratory Research | 2020 |
Elevated expression of BAFF receptor, BR3, on monocytes correlates with B cell activation and clinical features of patients with primary Sjögren’s syndrome
K Yoshimoto, K Suzuki, E Takei, Y Ikeda, T Takeuchi |
Arthritis Research & Therapy | 2020 |
Recent Advances in Mouse Models of Sjögren's Syndrome
Y Gao, Y Chen, Z Zhang, X Yu, J Zheng |
Frontiers in immunology | 2020 |
Primary Sjogren Syndrome: Focus on Innate Immune Cells and Inflammation
C Rizzo, G Grasso, GM Castaniti, F Ciccia, G Guggino |
Human vaccines | 2020 |
High-throughput investigation of molecular and cellular biomarkers in NMOSD
SS Yandamuri, R Jiang, A Sharma, E Cotzomi, C Zografou, AK Ma, JS Alvey, LJ Cook, TJ Smith, MR Yeaman, KC O'Connor |
Neurology: Neuroimmunology & Neuroinflammation | 2020 |
Contributions of Major Cell Populations to Sjögren’s Syndrome
R Witas, S Gupta, CQ Nguyen |
Journal of Clinical Medicine | 2020 |
Pathogenetic Mechanisms Implicated in Sjögren’s Syndrome Lymphomagenesis: A Review of the Literature
IE Stergiou, A Poulaki, M Voulgarelis |
Journal of Clinical Medicine | 2020 |
Mouse Models of Sjögren’s Syndrome with Ocular Surface Disease
S Masli, DA Dartt |
International journal of molecular sciences | 2020 |
Studying Sjögren's syndrome in mice: What is the best available model?
G Abughanam, OM Mari, SD Tran |
Journal of Oral Biology and Craniofacial Research | 2020 |
Innate Immunity and Biological Therapies for the Treatment of Sjögren’s Syndrome
A Srivastava, HP Makarenkova |
International journal of molecular sciences | 2020 |
Investigative biological therapies for primary Sjögren’s syndrome
He SH, Xuan YY, Liang X, Guo KJ, Wang Y, Fu XN, Li TF |
Archives of Medical Science : AMS | 2020 |
Serum markers of B-cell activation in pregnancy during late gestation, delivery, and the postpartum period
J Lima, G Cambridge, A Vilas-Boas, C Martins, LM Borrego, M Leandro |
American Journal of Reproductive Immunology | 2019 |
Current Clinical Trials in Pemphigus and Pemphigoid
K Izumi, K Bieber, RJ Ludwig |
Frontiers in immunology | 2019 |
BAFF inhibition in SLE—Is tolerance restored?
SW Jackson, A Davidson |
Immunological Reviews | 2019 |
Physiology, Pathology and Regeneration of Salivary Glands
Porcheri, Mitsiadis |
Cells | 2019 |
Lupus serum IgG induces microglia activation through Fc fragment dependent way and modulated by B-cell activating factor
C Yang, X Hou, Q Feng, Y Li, X Wang, L Qin, P Yang |
Journal of Translational Medicine | 2019 |
Tertiary Lymphoid Structures: Autoimmunity Goes Local
E Pipi, S Nayar, DH Gardner, S Colafrancesco, C Smith, F Barone |
Frontiers in immunology | 2018 |
Accumulation of Antigen-Driven Lymphoproliferations in Complement Receptor 2/CD21 −/low B Cells From Patients With Sjögren's Syndrome
S Glauzy, M Boccitto, JM Bannock, FR Delmotte, D Saadoun, P Cacoub, JA Ice, KL Sivils, JA James, SL Wolin, E Meffre |
Arthritis & Rheumatology | 2018 |
Tailoring Immune Responses toward Autoimmunity: Transcriptional Regulators That Drive the Creation and Collusion of Autoreactive Lymphocytes
KL Good-Jacobson, JR Groom |
Frontiers in immunology | 2018 |
Acquisition of N-Glycosylation Sites in Immunoglobulin Heavy Chain Genes During Local Expansion in Parotid Salivary Glands of Primary Sjögren Patients
A Visser, ME Doorenspleet, N de Vries, FK Spijkervet, A Vissink, RJ Bende, H Bootsma, FG Kroese, NA Bos |
Frontiers in immunology | 2018 |
Immunophenotypes and clinical features of lymphocytes in the labial gland of primary Sjogren's syndrome patients
W Sun, N Zhang, Y Zhang, Z Shao, L Gong, W Wei |
Journal of Clinical Laboratory Analysis | 2018 |
B-cell activity markers are associated with different disease activity domains in primary Sjögren’s syndrome
K James, C Chipeta, A Parker, S Harding, SJ Cockell, CS Gillespie, J Hallinan, F Barone, SJ Bowman, WF Ng, BA Fisher |
Rheumatology | 2018 |
BAFF-neutralizing interaction of belimumab related to its therapeutic efficacy for treating systemic lupus erythematosus
W Shin, HT Lee, H Lim, SH Lee, JY Son, JU Lee, KY Yoo, SE Ryu, J Rhie, JY Lee, YS Heo |
Nature Communications | 2018 |
Current Insights in Microbiome Shifts in Sjogren’s Syndrome and Possible Therapeutic Interventions
C Tsigalou, E Stavropoulou, E Bezirtzoglou |
Frontiers in immunology | 2018 |
Integrated B Cell, Toll-like, and BAFF Receptor Signals Promote Autoantibody Production by Transitional B Cells
SW Du, HM Jacobs, T Arkatkar, DJ Rawlings, SW Jackson |
Journal of immunology (Baltimore, Md. : 1950) | 2018 |
Current and Emerging Evidence for Toll-Like Receptor Activation in Sjögren’s Syndrome
J Kiripolsky, JM Kramer |
Journal of Immunology Research | 2018 |
Smoking, disease characteristics and serum cytokine levels in patients with primary Sjögren’s syndrome
P Olsson, K Skogstrand, A Nilsson, C Turesson, LT Jacobsson, E Theander, G Houen, T Mandl |
Rheumatology International | 2018 |
Phosphatidylinositol 3-kinase delta pathway: a novel therapeutic target for Sjögren’s syndrome
S Nayar, J Campos, CG Smith, V Iannizzotto, DH Gardner, S Colafrancesco, E Pipi, F Kollert, KJ Hunter, C Brewer, CD Buckley, SJ Bowman, R Priori, G Valesini, M Juarez, WA Fahy, BA Fisher, A Payne, RA Allen, F Barone |
Annals of the rheumatic diseases | 2018 |
B cells in the pathogenesis of primary Sjögren syndrome
G Nocturne, X Mariette |
Nature Reviews Rheumatology | 2018 |
H1N1 vaccination in Sjögren’s syndrome triggers polyclonal B cell activation and promotes autoantibody production
S Brauner, L Folkersen, M Kvarnström, S Meisgen, S Petersen, M Franzén-Malmros, J Mofors, KA Brokstad, L Klareskog, R Jonsson, LS Westerberg, C Trollmo, V Malmström, A Ambrosi, VK Kuchroo, G Nordmark, M Wahren-Herlenius |
Annals of the rheumatic diseases | 2017 |
A mouse model of systemic lupus erythematosus responds better to soluble TACI than to soluble BAFFR, correlating with depletion of plasma cells
P Haselmayer, M Vigolo, J Nys, P Schneider, H Hess |
European Journal of Immunology | 2017 |
Comparison of non-invasive biomarkers faecal BAFF, calprotectin and FOBT in discriminating IBS from IBD and evaluation of intestinal inflammation
Y Fu, L Wang, C Xie, K Zou, L Tu, W Yan, X Hou |
Scientific Reports | 2017 |
New insights into the pathogenesis of IgA nephropathy
SC Yeo, CK Cheung, J Barratt |
Pediatric Nephrology | 2017 |
CD19 regulates ADAM28-mediated Notch2 cleavage to control the differentiation of marginal zone precursors to MZ B cells
Y Zhang, G Zhu, H Xiao, X Liu, G Han, G Chen, C Hou, B Shen, Y Li, N Ma, R Wang |
Journal of Cellular and Molecular Medicine | 2017 |
B cell activating factor (BAFF) and BAFF receptors: fakes and facts: BAFF and BAFF receptors
G Ferraccioli, E Gremese |
Clinical & Experimental Immunology | 2017 |
Env-Specific Antibodies in Chronic Infection versus in Vaccination
M Soldemo, GB Hedestam |
Frontiers in immunology | 2017 |
The Pathophysiology of Dry Eye Disease
SC Pflugfelder, CS de Paiva |
Ophthalmology | 2017 |
The Role of BAFF System Molecules in Host Response to Pathogens
J Sakai, M Akkoyunlu |
Clinical microbiology reviews | 2017 |
Predictable biomarkers of developing lymphoma in patients with Sjögren syndrome: a nationwide population-based cohort study
YH Chiu, CH Chung, KT Lin, CS Lin, JH Chen, HC Chen, RY Huang, CT Wu, FC Liu, WC Chien |
Oncotarget | 2017 |
Sjogren's syndrome: Review of the aetiology, Pathophysiology a Potential therapeutic interventions
JJ Nair, TP Singh |
Journal of Clinical and Experimental Dentistry | 2017 |
Sex differential association of dermatomyositis with Sjögren syndrome
CC Tseng, SJ Chang, WC Tsai, TT Ou, CC Wu, WY Sung, MC Hsieh, JH Yen |
CMAJ : Canadian Medical Association Journal | 2017 |
B Cells Are Indispensable for a Novel Mouse Model of Primary Sjögren’s Syndrome
J Zheng, Q Huang, R Huang, F Deng, X Yue, J Yin, W Zhao, Y Chen, L Wen, J Zhou, R Huang, G Riemekasten, Z Liu, F Petersen, X Yu |
Frontiers in immunology | 2017 |
B-Cell-Activating Factor and the B-Cell Compartment in HIV/SIV Infection
G Borhis, M Trovato, N Chaoul, HM Ibrahim, Y Richard |
Frontiers in immunology | 2017 |
Innate immunity in Sjögren's syndrome
J Kiripolsky, LG McCabe, JM Kramer |
Clinical Immunology | 2017 |
What can Sjögren's syndrome-like disease in mice contribute to human Sjögren's syndrome?
AB Peck, CQ Nguyen |
Clinical Immunology | 2017 |
Role of Natural Autoantibodies and Natural IgM Anti-Leucocyte Autoantibodies in Health and Disease
PI Lobo |
Frontiers in immunology | 2016 |
Aquaporin gene therapy corrects Sjögren’s syndrome phenotype in mice
Z Lai, H Yin, J Cabrera-Pérez, MC Guimaro, S Afione, DG Michael, P Glenton, A Patel, WD Swaim, C Zheng, CQ Nguyen, F Nyberg, JA Chiorini |
Proceedings of the National Academy of Sciences | 2016 |
B Cell-Activating Factor as a New Potential Marker in Inflammatory Bowel Disease
P Zhang, X Liu, A Guo, J Xiong, Y Fu, K Zou |
Digestive Diseases and Sciences | 2016 |
B Cell-Activating Factor (BAFF)-Targeted B Cell Therapies in Inflammatory Bowel Diseases
M Uzzan, JF Colombel, A Cerutti, X Treton, S Mehandru |
Digestive Diseases and Sciences | 2016 |
Early BAFF receptor blockade mitigates murine Sjögren's syndrome: Concomitant targeting of CXCL13 and the BAFF receptor prevents salivary hypofunction
A Sharma, J Kiripolsky, E Klimatcheva, A Howell, F Fereidouni, R Levenson, TL Rothstein, JM Kramer |
Clinical Immunology | 2016 |
Recent advances in primary Sjogren's syndrome
N Holdgate, EW St.Clair |
F1000Research | 2016 |
Analysis of Associations of Human BAFF Gene Polymorphisms with Autoimmune Thyroid Diseases
JD Lin, SF Yang, YH Wang, WF Fang, YC Lin, YF Lin, KT Tang, MY Wu, CW Cheng, H Ariga |
PloS one | 2016 |
Rituximab Effectiveness and Safety for Treating Primary Sjögren’s Syndrome (pSS): Systematic Review and Meta-Analysis
FB Souza, GJ Porfírio, BN Andriolo, JV de Albuquerque, VF Trevisani, S Appel |
PloS one | 2016 |
Multiple Roles for B-Lymphocytes in Sjogren’s Syndrome
J Ambrus, L Suresh, A Peck |
Journal of Clinical Medicine | 2016 |
CD40 SIGNALING IN GRAVES’ DISEASE IS MEDIATED THROUGH CANONICAL AND NON-CANONICAL THYROIDAL NF-κB ACTIVATION
HJ Lee, A Lombardi, M Stefan, C Li, WB Inabnet, RP Owen, E Concepcion, Y Tomer |
Endocrinology | 2016 |
The osteopontin transgenic mouse is a new model for Sjögren's syndrome
S Husain-Krautter, JM Kramer, W Li, B Guo, TL Rothstein |
Clinical Immunology | 2015 |
Altered BCR and TLR signals promote enhanced positive selection of autoreactive transitional B cells in Wiskott-Aldrich syndrome
NS Kolhatkar, A Brahmandam, CD Thouvenel, S Becker-Herman, HM Jacobs, MA Schwartz, EJ Allenspach, S Khim, AK Panigrahi, ET Prak, AJ Thrasher, LD Notarangelo, F Candotti, TR Torgerson, I Sanz, DJ Rawlings |
Journal of Experimental Medicine | 2015 |
Analysis of IgM antibody production and repertoire in a mouse model of Sjo grens syndrome
JM Kramer, NE Holodick, TC Vizconde, I Raman, M Yan, QZ Li, DP Gaile, TL Rothstein |
Journal of leukocyte biology | 2015 |
The Coexistence of Sjögren's Syndrome and Primary Biliary Cirrhosis: A Comprehensive Review
Y Sun, W Zhang, B Li, Z Zou, C Selmi, ME Gershwin |
Clinical Reviews in Allergy & Immunology | 2015 |
Current and emerging treatment options for ANCA-associated vasculitis: potential role of belimumab and other BAFF/APRIL targeting agents
P Lenert, A Lenert |
Drug design, development and therapy | 2015 |
B-cell reconstitution after lentiviral vector–mediated gene therapy in patients with Wiskott-Aldrich syndrome
MC Castiello, S Scaramuzza, F Pala, F Ferrua, P Uva, I Brigida, L Sereni, M der Burg, G Ottaviano, MH Albert, MG Roncarolo, L Naldini, A Aiuti, A Villa, M Bosticardo |
Journal of Allergy and Clinical Immunology | 2015 |
Association of BAFF −871C/T Promoter Polymorphism with Hepatitis C-Related Mixed Cryoglobulinemia in a Cohort of Egyptian Patients
MW Ayad, AA Elbanna, DA Elneily, AS Sakr |
Molecular diagnosis & therapy | 2015 |
Factors Regulating Immunoglobulin Production by Normal and Disease-Associated Plasma Cells
D Jackson, S Elsawa |
Biomolecules | 2015 |
The clinical relevance of animal models in Sjögren’s syndrome: the interferon signature from mouse to man
NI Maria, P Vogelsang, MA Versnel |
Arthritis Research & Therapy | 2015 |
B-cell survival factors in autoimmune rheumatic disorders
SA Morais, A Vilas-Boas, DA Isenberg |
Therapeutic Advances in Musculoskeletal Diseases | 2015 |
CsBAFF, a Teleost B Cell Activating Factor, Promotes Pathogen-Induced Innate Immunity and Vaccine-Induced Adaptive Immunity
Y Sun, L Sun, Y Richard |
PloS one | 2015 |
The relationship between the presence of autoantibodies, indicators of local and systemic inflammation, the serum concentration of B-cell activating factor (BAFF) and the intensity of salivary gland infiltration in patients with primary Sjögren’s syndrome – a preliminary study
M Maślińska, E Kontny, B Kwiatkowska |
Reumatologia/Rheumatology | 2015 |
Targeting of Ly9 (CD229) Disrupts Marginal Zone and B1 B Cell Homeostasis and Antibody Responses
M Cuenca, X Romero, J Sintes, C Terhorst, P Engel |
Journal of immunology (Baltimore, Md. : 1950) | 2015 |
The Expression of BAFF Is Controlled by IRF Transcription Factors
M Sjostrand, A Johansson, L Aqrawi, T Olsson, M Wahren-Herlenius, A Espinosa |
Journal of immunology (Baltimore, Md. : 1950) | 2015 |
Mouse models of primary Sjögren’s syndrome
Park YS, Gauna AE, Cha S |
Current pharmaceutical design | 2015 |
Interleukins and interleukin receptors in rheumatoid arthritis: Research, diagnostics and clinical implications
Lili Magyari, Dalma Varszegi, Erzsebet Kovesdi, Patricia Sarlos, Bernadett Farago, Andras Javorhazy, Katalin Sumegi, Zsolt Banfai, Bela Melegh |
World Journal of Orthopedics | 2014 |
Matriptase Deletion Initiates a Sjögren's Syndrome-Like Disease in Mice
H Yin, P Kosa, X Liu, WD Swaim, Z Lai, J Cabrera-Perez, GD Pasquale, IS Ambudkar, TH Bugge, JA Chiorini |
PloS one | 2014 |
Novel treatments for immune thrombocytopenia
A Shih, I Nazi, JG Kelton, DM Arnold |
La Presse Médicale | 2014 |
Acquired Hemophilia A: A Frequently Overlooked Autoimmune Hemorrhagic Disorder
Y Sakurai, T Takeda |
Journal of Immunology Research | 2014 |
Therapeutic Effects of PADRE-BAFF Autovaccine on Rat Adjuvant Arthritis
G Feng, X Xue, M Gao, X Wang, Z Shu, N Mu, Y Gao, Z Wang, Q Hao, W Li, M Li, C Zhang, W Zhang, Y Zhang |
BioMed Research International | 2014 |
BAFF activates Erk1/2 promoting cell proliferation and survival by Ca2+-CaMKII-dependent inhibition of PP2A in normal and neoplastic B-lymphoid cells
D Liang, Q Zeng, Z Xu, H Zhang, L Gui, C Xu, S Chen, S Zhang, S Huang, L Chen |
Biochemical Pharmacology | 2014 |
Reduced BAFF-R and Increased TACI Expression in Common Variable Immunodeficiency
RR Barbosa, SL Silva, SP Silva, AC Melo, MC Pereira-Santos, JT Barata, L Hammarström, M Cascalho, AE Sousa |
Journal of Clinical Immunology | 2014 |
Distinct Effects of Methotrexate and Etanercept on the B Cell Compartment in Patients With Juvenile Idiopathic Arthritis: MTX and Etanercept Differentially Affect B Cells in JIA
S Glaesener, TD Quách, N Onken, F Weller-Heinemann, F Dressler, HI Huppertz, A Thon, A Meyer-Bahlburg |
Arthritis & Rheumatology | 2014 |
Genome-wide gene expression profiling reveals unsuspected molecular alterations in pemphigus foliaceus
D Malheiros, RA Panepucci, AM Roselino, AG Araújo, MA Zago, ML Petzl-Erler |
Immunology | 2014 |
Autoimmunity in the Pathogenesis and Treatment of Keratoconjunctivitis Sicca
KC Liu, K Huynh, J Grubbs, RM Davis |
Current Allergy and Asthma Reports | 2014 |
Elevation of Serum B-Cell Activating Factor Levels During Visceral Leishmaniasis
Y Goto, S Omachi, C Sanjoba, Y Matsumoto |
The American journal of tropical medicine and hygiene | 2014 |
The value of animal models to study immunopathology of primary human Sjögren's syndrome symptoms
A Donate, A Voigt, CQ Nguyen |
Expert Review of Clinical Immunology | 2014 |
Expansion of autoreactive unresponsive CD21-/low B cells in Sjögren's syndrome-associated lymphoproliferation
D Saadoun, B Terrier, J Bannock, T Vazquez, C Massad, I Kang, F Joly, M Rosenzwajg, D Sene, P Benech, L Musset, D Klatzmann, E Meffre, P Cacoub |
Arthritis & Rheumatism | 2013 |
BMP6 is associated with exocrine gland dysfunction in Sjögren's syndrome patients and mice
H Yin, J Cabrera-Perez, Z Lai, D Michael, M Weller, W Swaim, X Liu, MA Catalán, EM Rocha, N Ismail, S Afione, N Rana, GD Pasquale, I Alevizos, I Ambudkar, GG Illei, JA Chiorini |
Arthritis & Rheumatism | 2013 |
CXCL13 is elevated in Sjögren's syndrome in mice and humans and is implicated in disease pathogenesis
JM Kramer, E Klimatcheva, TL Rothstein |
Journal of leukocyte biology | 2013 |
Wiskott-Aldrich Syndrome protein deficiency perturbs the homeostasis of B-cell compartment in humans
MC Castiello, M Bosticardo, F Pala, M Catucci, N Chamberlain, MC van Zelm, GJ Driessen, M Pac, E Bernatowska, S Scaramuzza, A Aiuti, AV Sauer, E Traggiai, E Meffre, A Villa, M der Burg |
Journal of Autoimmunity | 2013 |
Empfehlungen zum Einsatz von Belimumab beim systemischen Lupus erythematodes
R Fischer-Betz, M Schneider |
Zeitschrift für Rheumatologie | 2013 |
B-cell activating factor (BAFF) is elevated in Chronic Granulomatous Disease
K Matharu, KA Zarember, BE Marciano, DB Kuhns, C Spalding, M Garofalo, T Dimaggio, T Estwick, CY Huang, D Fink, DL Priel, TA Fleisher, SM Holland, HL Malech, JI Gallin |
Clinical Immunology | 2013 |
Noxa in rheumatic diseases: present understanding and future impact
KE Cottier, EM Fogle, DA Fox, S Ahmed |
Rheumatology | 2013 |
Emerging cell and cytokine targets in rheumatoid arthritis
GR Burmester, E Feist, T Dörner |
Nature Reviews Rheumatology | 2013 |
Targeting the Splicing of mRNA in Autoimmune Diseases: BAFF Inhibition in Sjögren’s Syndrome as a Proof of Concept
N Roescher, JL Vosters, G Alsaleh, P Dreyfus, S Jacques, G Chiocchia, J Sibilia, PP Tak, JA Chiorini, X Mariette, JE Gottenberg |
Molecular Therapy | 2013 |
Efficacy and safety of rituximab treatment in early primary Sjögren's syndrome: a prospective, multi-center, follow-up study
F Carubbi, P Cipriani, A Marrelli, P Benedetto, P Ruscitti, O Berardicurti, I Pantano, V Liakouli, S Alvaro, A Alunno, A Manzo, F Ciccia, R Gerli, G Triolo, R Giacomelli |
Arthritis Research & Therapy | 2013 |
The immune factors involved in the pathogenesis, diagnosis, and treatment of Sjogren's syndrome
Y Huang, Q Cheng, C Jiang, S An, L Xiao, Y Gou, W Yu, L Lei, Q Chen, Y Wang, J Wang |
Clinical & developmental immunology | 2013 |
Possible Mechanisms of Lymphoma Development in Sjögren's Syndrome
L Dong, Y Chen, Y Masaki, T Okazaki, H Umehara |
Current immunology reviews | 2013 |
The Characteristics and Significance of Locally Infiltrating B Cells in Lupus Nephritis and Their Association with Local BAFF Expression
CY Sun, Y Shen, XW Chen, YC Yan, FX Wu, M Dai, T Li, CD Yang |
International Journal of Rheumatology | 2013 |
B-lymphocyte tolerance and effector function in immunity and autoimmunity
WN Khan, JA Wright, E Kleiman, JC Boucher, I Castro, ES Clark |
Immunologic Research | 2013 |
Rituximab Therapy for Primary Sjögren's Syndrome: An Open-Label Clinical Trial and Mechanistic Analysis: Rituximab Therapy For Primary Sjögren's Syndrome
EW St.Clair, MC Levesque, ET Prak, FB Vivino, CJ Alappatt, ME Spychala, J Wedgwood, J McNamara, KL Sivils, L Fisher, P Cohen |
Arthritis & Rheumatism | 2013 |
A (selective) history of Australian involvement in cytokine biology
NA Nicola |
Cytokine & Growth Factor Reviews | 2013 |
Effects of prostaglandin E2 on p53 mRNA transcription and p53 mutagenesis during T-cell-independent human B-cell clonal expansion
S Haque, XJ Yan, L Rosen, S McCormick, N Chiorazzi, PK Mongini |
The FASEB Journal | 2013 |
Murine BAFF expression is up-regulated by estrogen and interferons: Implications for sex bias in the development of autoimmunity
R Panchanathan, D Choubey |
Molecular Immunology | 2013 |
Excess CD40L does not rescue anti-DNA B cells from clonal anergy
M Aslam, Y Kishi, T Tsubata |
F1000Research | 2013 |
Excess CD40L does not rescue anti-DNA B cells from clonal anergy
M Aslam, Y Kishi, T Tsubata |
F1000Research | 2013 |
B-Cell-Activating Factor Affects the Occurrence of Thyroid Autoimmunity in Chronic Hepatitis C Patients Treated with Interferon Alpha
Y Kajiyama, K Kikuchi, A Takai, N Hosoya, H Hoshino, K Hino, H Miyakawa |
Clinical and Developmental Immunology | 2012 |
B cells as effectors and regulators of sex-biased arthritis
D Luckey, K Medina, V Taneja |
Autoimmunity | 2012 |
The Interplay of IL-21 and BAFF in the Formation and Maintenance of Human B Cell Memory
JL Karnell, R Ettinger |
Frontiers in immunology | 2012 |
B-cell tolerance defects in the B6.Aec1/2 mouse model of Sjögren's syndrome
W Meng, Y Li, E Xue, M Satoh, AB Peck, PL Cohen, RA Eisenberg, ET Prak |
Journal of Clinical Immunology | 2012 |
APRIL, a proliferation-inducing ligand, as a potential marker of lupus nephritis
W Treamtrakanpon, P Tantivitayakul, T Benjachat, P Somparn, W Kittikowit, S Eiam-Ong, A Leelahavanichkul, N Hirankarn, Y Avihingsanon |
Arthritis Research & Therapy | 2012 |
Prevalence of interferon type I signature in CD14 monocytes of patients with Sjogren's syndrome and association with disease activity and BAFF gene expression
Z Brkic, NI Maria, CG van Helden-Meeuwsen, JP van de Merwe, PL van Daele, VA Dalm, ME Wildenberg, W Beumer, HA Drexhage, MA Versnel |
Annals of the rheumatic diseases | 2012 |
A p53 axis regulates B cell receptor-triggered, innate immune system-driven B cell clonal expansion
H Lee, S Haque, J Nieto, J Trott, JK Inman, S McCormick, N Chiorazzi, PK Mongini |
Journal of immunology (Baltimore, Md. : 1950) | 2012 |
Cellular Targeting in Autoimmunity
JL Rogers, DS Serafin, RG Timoshchenko, TK Tarrant |
Current Allergy and Asthma Reports | 2012 |
Type I interferon signature is high in lupus and neuromyelitis optica but low in multiple sclerosis
X Feng, NP Reder, M Yanamandala, A Hill, BS Franek, TB Niewold, AT Reder, A Javed |
Journal of the Neurological Sciences | 2012 |
Gene cloning, expression and functional characterization of a proliferation-inducing ligand (APRIL) from hedgehog (Erinaceus europaeus)
X Cui, W Xiao, C Ji, A Tian, J Zhang, S Zhang |
Molecular Biology Reports | 2012 |
Lactoferrin Stimulates Mouse Macrophage to Express BAFF via Smad3 Pathway
HK Chang, BR Jin, YS Jang, WS Kim, PH Kim |
Immune Network | 2012 |
Signaling by the TNFR superfamily in B-cell biology and disease
RC Rickert, J Jellusova, AV Miletic |
Immunological Reviews | 2011 |
B cell depletion in autoimmune diabetes: insights from murine models
JL Chamberlain, K Attridge, CJ Wang, GA Ryan, LS Walker |
Expert Opinion on Therapeutic Targets | 2011 |
Sjögren's syndrome: studying the disease in mice
N Delaleu, CQ Nguyen, AB Peck, R Jonsson |
Arthritis Research & Therapy | 2011 |
Biomarkers in chronic graft-versus-host disease
J Rozmus, KR Schultz |
Expert Review of Hematology | 2011 |
Beyond transitional selection: New roles for BLyS in peripheral tolerance
MA Oropallo, K Kiefer, A Marshak-Rothstein, MP Cancro |
Drug Development Research | 2011 |
Lymphotoxin-beta receptor blockade reduces CXCL13 in lacrimal glands and improves corneal integrity in the NOD model of Sjögren's syndrome
RA Fava, SM Kennedy, SG Wood, AI Bolstad, J Bienkowska, A Papandile, JA Kelly, CP Mavragani, M Gatumu, K Skarstein, JL Browning |
Arthritis Research & Therapy | 2011 |
Aspects of innate immunity in Sjögren's syndrome
HZ Low, T Witte |
Arthritis Research & Therapy | 2011 |
What have we learned from clinical trials in primary Sjögren's syndrome about pathogenesis?
CG Kallenberg, A Vissink, FG Kroese, WH Abdulahad, H Bootsma |
Arthritis Research & Therapy | 2011 |
The Plasma Concentration of the B Cell Activating Factor Is Increased in Children With Acute Malaria
E Nduati, A Gwela, H Karanja, C Mugyenyi, J Langhorne, K Marsh, BC Urban |
The Journal of Infectious Diseases | 2011 |
Liver-expressed Igκ superantigen induces tolerance of polyclonal B cells by clonal deletion not κ to λ receptor editing
T Ota, M Ota, BH Duong, AL Gavin, D Nemazee |
Journal of Experimental Medicine | 2011 |
Loss of PKCδ results in characteristics of Sjögren’s syndrome including salivary gland dysfunction
GP Banninger, S Cha, MS Said, KM Pauley, CJ Carter, M Onate, BA Pauley, SM Anderson, ME Reyland |
Oral Diseases | 2011 |
Regulatory mechanisms for the production of BAFF and IL-6 are impaired in monocytes of patients of primary Sjögren's syndrome
K Yoshimoto, M Tanaka, M Kojima, Y Setoyama, H Kameda, K Suzuki, K Tsuzaka, Y Ogawa, K Tsubota, T Abe, T Takeuchi |
Arthritis Research & Therapy | 2011 |
Disturbance of cytokine networks in Sjögren's syndrome
P Youinou, JO Pers |
Arthritis Research & Therapy | 2011 |
BAFF Promotes Th17 Cells and Aggravates Experimental Autoimmune Encephalomyelitis
X Zhou, Z Xia, Q Lan, J Wang, W Su, YP Han, H Fan, Z Liu, W Stohl, SG Zheng |
PloS one | 2011 |
Piecing together the humoral and cellular mechanisms of immune thrombocytopenia
LJ Toltl, I Nazi, R Jafari, DM Arnold |
Seminars in thrombosis and hemostasis | 2011 |
TACI-Fc gene therapy improves auto-immune sialadenitis but not salivary gland function in NOD mice
JL Vosters, N Roescher, GG Illei, JA Chiorini, PP Tak |
Oral Diseases | 2011 |
Regulation of B cell activating factor (BAFF) receptor expression by NF-κB signaling in rheumatoid arthritis B cells
YJ Woo, BY Yoon, JY Jhun, HJ Oh, S Min, ML Cho, SH Park, HY Kim, JK Min |
Experimental & molecular medicine | 2011 |
Genetics and genomics of Sjögren's syndrome: research provides clues to pathogenesis and novel therapies
BM Segal, AN Nazmul-Hossain, K Patel, P Hughes, KL Moser, NL Rhodus |
Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology | 2011 |
Activin A Stimulates Mouse APCs to Express BAFF via ALK4-Smad3 Pathway
JH Kim, GY Seo, PH Kim |
Immune Network | 2011 |
Animal Models in Autoimmune Diseases: Lessons Learned from Mouse Models for Sjögren’s Syndrome
BH Lee, AE Gauna, KM Pauley, YJ Park, S Cha |
Clinical Reviews in Allergy & Immunology | 2011 |
Temporal changes in salivary glands of non-obese diabetic mice as a model for Sjögren’s syndrome: Temporal changes in salivary glands of NOD mice
N Roescher, BM Lodde, JL Vosters, PP Tak, MA Catalan, GG Illei, JA Chiorini |
Oral Diseases | 2011 |
Autoimmunity at the ocular surface: pathogenesis and regulation
ME Stern, CS Schaumburg, R Dana, M Calonge, JY Niederkorn, SC Pflugfelder |
Mucosal Immunology | 2010 |
Homeostatic expansion of autoreactive immunoglobulin-secreting cells in the Rag2 mouse model of Omenn syndrome
B Cassani, PL Poliani, V Marrella, F Schena, AV Sauer, M Ravanini, D Strina, CE Busse, S Regenass, H Wardemann, A Martini, F Facchetti, M der Burg, AG Rolink, P Vezzoni, F Grassi, E Traggiai, A Villa |
Journal of Experimental Medicine | 2010 |
Current concepts: mouse models of Sjögren's syndrome
TN Lavoie, BH Lee, CQ Nguyen |
Journal of biomedicine & biotechnology | 2010 |
Expansion of immunoglobulin-secreting cells and defects in B cell tolerance in Rag-dependent immunodeficiency
JE Walter, F Rucci, L Patrizi, M Recher, S Regenass, T Paganini, M Keszei, I Pessach, PA Lang, PL Poliani, S Giliani, W Al-Herz, MJ Cowan, JM Puck, J Bleesing, T Niehues, C Schuetz, H Malech, SS DeRavin, F Facchetti, AR Gennery, E Andersson, NR Kamani, JA Sekiguchi, HM Alenezi, J Chinen, G Dbaibo, G ElGhazali, A Fontana, S Pasic, C Detre, C Terhorst, FW Alt, LD Notarangelo |
Journal of Experimental Medicine | 2010 |
B-cell homeostasis requires complementary CD22 and BLyS/BR3 survival signals
SH Smith, KM Haas, JC Poe, K Yanaba, CD Ward, TS Migone, TF Tedder |
International Immunology | 2010 |
Direct B-cell Stimulation by Peripheral Blood Monocyte-derived Dendritic Cells in Idiopathic Thrombocytopenic Purpura Patients
Z Zhou, X Li, J Li, C Su, L Zhuang, S Luo, L Zhang |
Journal of Clinical Immunology | 2010 |
Current Aspects of Pathogenesis in Sjögren's Syndrome
M Voulgarelis, AG Tzioufas |
Therapeutic Advances in Musculoskeletal Diseases | 2010 |
The adaptor molecule Act1 regulates BAFF responsiveness and self-reactive B cell selection during transitional B cell maturation
NV Giltiay, Y Lu, D Allman, TN Jørgensen, X Li |
Journal of immunology (Baltimore, Md. : 1950) | 2010 |
Treating Sjögren's Syndrome: Insights for the Clinician
C Vitali, G Palombi, P Cataleta |
Therapeutic Advances in Musculoskeletal Diseases | 2010 |
Alloimmune response results in expansion of autoreactive donor CD4+ T cells in transplants that can mediate chronic graft-versus-host disease
D Zhao, JS Young, YH Chen, E Shen, T Yi, I Todorov, PG Chu, SJ Forman, D Zeng |
Journal of immunology (Baltimore, Md. : 1950) | 2010 |
BAFF overexpression promotes anti-dsDNA B-cell maturation and antibody secretion
M Thorn, RH Lewis, A Mumbey-Wafula, S Kantrowitz, LA Spatz |
Cellular Immunology | 2010 |
Hydroxychloroquine improves dry eye symptoms of patients with primary Sjogren’s syndrome
S Yavuz, E Asfuroğlu, M Bicakcigil, E Toker |
Rheumatology International | 2010 |
Pathogenetic mechanisms in the initiation and perpetuation of Sjögren's syndrome
M Voulgarelis, AG Tzioufas |
Nature Reviews Rheumatology | 2010 |
Negative Feedback in Noncanonical NF-κB Signaling Modulates NIK Stability Through IKKα-Mediated Phosphorylation
B Razani, B Zarnegar, AJ Ytterberg, T Shiba, PW Dempsey, CF Ware, JA Loo, G Cheng |
Science signaling | 2010 |
Altered B-cell homeostasis and excess BAFF in human chronic graft-versus-host disease
S Sarantopoulos, KE Stevenson, HT Kim, CS Cutler, NS Bhuiya, M Schowalter, VT Ho, EP Alyea, J Koreth, BR Blazar, RJ Soiffer, JH Antin, J Ritz |
Blood | 2009 |
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd |
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology | 2009 |
Abnormal B-cell activation associated with TALL-1 over-expression and SOCS-1 suppression during chronic hepatitis C virus infection
J Moorman, ZP Dong, L Ni, C Zhang, T Borthwick, ZQ Yao |
Immunology | 2009 |
Translational Mini-Review Series on B Cell-Directed Therapies: B cell-directed therapy for autoimmune diseases
C Hu, FS Wong, L Wen |
Clinical & Experimental Immunology | 2009 |
BAFF: a local and systemic target in autoimmune diseases
I Moisini, A Davidson |
Clinical & Experimental Immunology | 2009 |
B cells in autoimmunity
T Dörner, AM Jacobi, PE Lipsky |
Arthritis Research & Therapy | 2009 |
Chronic inflammatory disease, lymphoid tissue neogenesis and extranodal marginal zone B-cell lymphomas
RJ Bende, F Maldegem, CJ van Noesel |
Haematologica | 2009 |
Altered BAFF-receptor signaling and additional modifier loci contribute to systemic autoimmunity in A/WySnJ mice
CG Mayne, FE Nashold, Y Sasaki, CE Hayes |
European Journal of Immunology | 2009 |
A phase II, randomized, double-blind, placebo-controlled, dose-ranging study of belimumab in patients with active systemic lupus erythematosus
DJ Wallace, W Stohl, RA Furie, JR Lisse, JD McKay, JT Merrill, MA Petri, EM Ginzler, WW Chatham, WJ McCune, V Fernandez, MR Chevrier, ZJ Zhong, WW Freimuth |
Arthritis & Rheumatism | 2009 |
Translational Mini-Review Series on B Cell-Directed Therapies: Recent advances in B cell-directed biological therapies for autoimmune disorders
MC Levesque |
Clinical & Experimental Immunology | 2009 |
Cutting edge: Primary and secondary effects of CD19 deficiency on cells of the marginal zone
Y You, H Zhao, Y Wang, RH Carter |
Journal of immunology (Baltimore, Md. : 1950) | 2009 |
Genetic variation in B-cell-activating factor is associated with an increased risk of developing B-cell non-Hodgkin lymphoma
AJ Novak, SL Slager, ZS Fredericksen, AH Wang, MM Manske, S Ziesmer, M Liebow, WR Macon, SR Dillon, TE Witzig, JR Cerhan, SM Ansell |
Cancer research | 2009 |
Effects of acute and chronic inflammation on B-cell development and differentiation
D Cain, M Kondo, H Chen, G Kelsoe |
Journal of Investigative Dermatology | 2009 |
Autoimmunity and lymphomagenesis
LR Goldin, O Landgren |
International Journal of Cancer | 2009 |
An exploratory dose-escalating study investigating the safety, tolerability, pharmacokinetics and pharmacodynamics of intravenous atacicept in patients with systemic lupus erythematosus
C Pena-Rossi, E Nasonov, M Stanislav, V Yakusevich, O Ershova, N Lomareva, H Saunders, J Hill, I Nestorov |
Lupus | 2009 |
CD4+CD25+ T-Cells Control Autoimmunity in the Absence of B-Cells
E Marino, J Villanueva, S Walters, D Liuwantara, F Mackay, ST Grey |
Diabetes | 2009 |
Sjögren syndrome: Advances in the pathogenesis from animal models
JA Chiorini, D Cihakova, CE Ouellette, P Caturegli |
Journal of Autoimmunity | 2009 |
Kritischer Überblick zu Outcome-Parametern bei Patienten mit primärem Sjögren-Syndrom
E Feist, A Hansen |
Zeitschrift für Rheumatologie | 2009 |
Aktuelle therapeutische Optionen bei Sjögren-Syndrom
A Hansen, T Dörner |
Zeitschrift für Rheumatologie | 2009 |
B-Cell Reconstitution and BAFF After Alemtuzumab (Campath-1H) Treatment of Multiple Sclerosis
SA Thompson, JL Jones, AL Cox, DA Compston, AJ Coles |
Journal of Clinical Immunology | 2009 |
BAFF Is Increased in Renal Transplant Patients Following Treatment with Alemtuzumab
D Bloom, Z Chang, K Pauly, J Kwun, J Fechner, C Hayes, M Samaniego, S Knechtle |
American Journal of Transplantation | 2009 |
Expression of B-Cell Activating Factor Enhances Protective Immunity of a Vaccine against Pseudomonas aeruginosa
C Tertilt, J Joh, A Krause, P Chou, K Schneeweiss, RG Crystal, S Worgall |
Infection and immunity | 2009 |
Unraveling the Pathophysiology of Sjogren Syndrome-Associated Dry Eye Disease
Nguyen CQ, Peck AB |
The ocular surface | 2009 |
An NZW-derived interval on chromosome 7 moderates sialadenitis, but not insulitis in congenic NOD mice
Burt RA, Watkins L, Tan IK, Wang N, Quirk F, Mackin L, Morgan P, Zhang JG, Berzins SP, Morahan G, Brodnicki TC |
Journal of immunology (Baltimore, Md. : 1950) | 2009 |
Biomarker profiles in serum and saliva of experimental Sjögren's syndrome: associations with specific autoimmune manifestations
N Delaleu, H Immervoll, J Cornelius, R Jonsson |
Arthritis Research & Therapy | 2008 |
Deficiency of Act1, a critical modulator of B cell function, leads to development of Sjogren’s syndrome1
Y Qian, N Giltiay, J Xiao, Y Wang, J Tian, S Han, M Scott, R Carter, TN Jorgensen, X Li |
European Journal of Immunology | 2008 |
Biologic treatments for systemic rheumatic diseases
Y Shirota, GG Illei, NP Nikolov |
Oral Diseases | 2008 |
Raised intrathecal levels of APRIL and BAFF in patients with systemic lupus erythematosus: relationship to neuropsychiatric symptoms
A George-Chandy, E Trysberg, K Eriksson |
Arthritis Research & Therapy | 2008 |
Signaling pathways for B cell-activating factor (BAFF) and a proliferation-inducing ligand (APRIL) in human placenta
DL Langat, DA Wheaton, JS Platt, T Sifers, JS Hunt |
The American Journal of Pathology | 2008 |
Characterization of a late transitional B cell population highly sensitive to BAFF-mediated homeostatic proliferation
A Meyer-Bahlburg, SF Andrews, KO Yu, SA Porcelli, DJ Rawlings |
Journal of Experimental Medicine | 2008 |
Multiple signaling pathways promote B lymphocyte stimulator dependent B-cell growth and survival
RT Woodland, CJ Fox, MR Schmidt, PS Hammerman, JT Opferman, SJ Korsmeyer, DM Hilbert, CB Thompson |
Blood | 2008 |
Selecting highly sensitive non-obese diabetic mice for improving the study of Sjögren’s syndrome
W Xiao, Y Wu, J Zhang, W Ye, GT Xu |
Graefe's Archive for Clinical and Experimental Ophthalmology | 2008 |
Hepatitis C and Non-Hodgkin Lymphoma Among 4784 Cases and 6269 Controls From the International Lymphoma Epidemiology Consortium
SD Sanjose, Y Benavente, CM Vajdic, EA Engels, LM Morton, PM Bracci, JJ Spinelli, T Zheng, Y Zhang, S Franceschi, R Talamini, EA Holly, AE Grulich, JR Cerhan, P Hartge, W Cozen, P Boffetta, P Brennan, M Maynadié, P Cocco, R Bosch, L Foretova, A Staines, N Becker, A Nieters |
Clinical Gastroenterology and Hepatology | 2008 |
BLyS Regulates Adaptive Immune Responses by Directly Promoting Dendritic Cell Maturation
Chang SK, Mihalcik SA, Jelinek DF |
Journal of immunology (Baltimore, Md. : 1950) | 2008 |
Update on Targets of Biologic Therapies for Rheumatoid Arthritis.
Rasheed Z, Haqqi TM |
Current rheumatology reviews | 2008 |
Immune opsonins modulate BLyS/BAFF release in a receptor-specific fashion
Li X, Su K, Ji C, Szalai AJ, Wu J, Zhang Y, Zhou T, Kimberly RP, Edberg JC |
Journal of immunology (Baltimore, Md. : 1950) | 2008 |
Augmented interferon-α pathway activation in patients with Sjögren's syndrome treated with etanercept
CP Mavragani, TB Niewold, NM Moutsopoulos, SR Pillemer, SM Wahl, MK Crow |
Arthritis & Rheumatism | 2007 |
B cells in glomerulonephritis: focus on lupus nephritis
MR Clatworthy, KG Smith |
Seminars in Immunopathology | 2007 |
Regulation of lupus-related autoantibody production and clinical disease by Toll-like receptors
SR Christensen, MJ Shlomchik |
Seminars in Immunology | 2007 |
B cells in Sjögren's syndrome: indications for disturbed selection and differentiation in ectopic lymphoid tissue
A Hansen, PE Lipsky, T Dörner |
Arthritis Research & Therapy | 2007 |
BAFF and MyD88 signals promote a lupuslike disease independent of T cells
JR Groom, CA Fletcher, SN Walters, ST Grey, SV Watt, MJ Sweet, MJ Smyth, CR Mackay, F Mackay |
Journal of Experimental Medicine | 2007 |
Human endometriosis is associated with plasma cells and overexpression of B lymphocyte stimulator
A Hever, RB Roth, P Hevezi, ME Marin, JA Acosta, H Acosta, J Rojas, R Herrera, D Grigoriadis, E White, PJ Conlon, RA Maki, A Zlotnik |
Proceedings of the National Academy of Sciences | 2007 |
Developments in lupus 2006
A Hansen, F Hiepe, T Dörner |
Arthritis Research & Therapy | 2007 |
Tumor necrosis factor alpha activates release of B lymphocyte stimulator by neutrophils infiltrating the rheumatoid joint
LK Assi, SH Wong, A Ludwig, K Raza, C Gordon, M Salmon, JM Lord, D Scheel-Toellner |
Arthritis & Rheumatism | 2007 |
Notes on the kidney and its diseases for the neurologist
MS Zandi, AJ Coles |
Journal of neurology, neurosurgery, and psychiatry | 2007 |
Sequence Analysis of TNFRSF13b, Encoding TACI, in Patients with Systemic Lupus Erythematosus
U Salzer, J Birmelin, C Bacchelli, T Witte, U Buchegger-Podbielski, S Buckridge, R Rzepka, HB Gaspar, AJ Thrasher, RE Schmidt, I Melchers, B Grimbacher |
Journal of Clinical Immunology | 2007 |
Preliminary clinical measurement of the expression of B-cell activating factor in Chinese systemic lupus erythematosus patients
Z Lin, Y Dan-Rong, T Xiao-Qing, W Hao, G Hong-Lian, K Xian-Tao, Z Ren-Qian, L Jiyu |
Journal of Clinical Laboratory Analysis | 2007 |
Safety, pharmacokinetics and pharmacodynamics of atacicept in healthy volunteers
A Munafo, A Priestley, I Nestorov, J Visich, M Rogge |
European Journal of Clinical Pharmacology | 2007 |
Indikation und Option neuer immunmodulatorischer Therapien beim Sjögren-Syndrom
E Feist, T Dörner, A Hansen |
Zeitschrift für Rheumatologie | 2007 |
Animal Models of Sjögren’s Syndrome
MV Jonsson, N Delaleu, R Jonsson |
Clinical Reviews in Allergy & Immunology | 2007 |
The Role of Epithelial Cells in the Pathogenesis of Sjögren’s Syndrome
MN Manoussakis, EK Kapsogeorgou |
Clinical Reviews in Allergy & Immunology | 2007 |
T Lymphocytes in Sjögren’s Syndrome: Contributors to and Regulators of Pathophysiology
GE Katsifis, NM Moutsopoulos, SM Wahl |
Clinical Reviews in Allergy & Immunology | 2007 |
Clinical, Immunologic, and Molecular Factors Predicting Lymphoma Development in Sjogren’s Syndrome Patients
M Voulgarelis, FN Skopouli |
Clinical Reviews in Allergy & Immunology | 2007 |
A conspicuous role for B cells In Sjögren's syndrome
P Youinou, V Devauchelle, P Hutin, RL Berre, A Saraux, JO Pers |
Clinical Reviews in Allergy & Immunology | 2007 |
Clonality analysis of lymphoproliferative disorders in patients with Sjögren's syndrome: Sjögren's syndrome and lymphoproliferative disorder
L Dong, Y Masaki, T Takegami, ZX Jin, CR Huang, T Fukushima, T Sawaki, T Kawanami, T Saeki, K Kitagawa, S Sugai, T Okazaki, Y Hirose, H Umehara |
Clinical & Experimental Immunology | 2007 |
High serum levels of BAFF, APRIL, and TACI in common variable immunodeficiency
AK Knight, L Radigan, T Marron, A Langs, L Zhang, C Cunningham-Rundles |
Clinical Immunology | 2007 |
Similarities and differences between selective and non-selective BAFF blockade in murine SLE
Meera Ramanujam, Xiaobo Wang, Weiqing Huang, Zheng Liu, Lena Schiffer, Haiou Tao, Daniel Frank, Jeffrey Rice, Betty Diamond, Karl O.A. Yu, Steven Porcelli, and Anne Davidson. |
Journal of Clinical Investigation | 2006 |
Tumor Necrosis Factor/Tumor Necrosis Factor Receptor Family Members That Positively Regulate Immunity
T So, SW Lee, M Croft |
International Journal of Hematology | 2006 |
Decreased B cell activating factor receptor expression on peripheral lymphocytes associated with increased disease activity in primary Sjögren's syndrome and systemic lupus erythematosus
J Sellam, C Miceli-Richard, JE Gottenberg, M Ittah, F Lavie, C Lacabaratz, N Gestermann, A Proust, O Lambotte, X Mariette |
Annals of the rheumatic diseases | 2006 |
Differential effects on BAFF and APRIL levels in rituximab-treated patients with systemic lupus erythematosus and rheumatoid arthritis
T Vallerskog, M Heimbürger, I Gunnarsson, W Zhou, M Wahren-Herlenius, C Trollmo, V Malmström |
Arthritis Research & Therapy | 2006 |
Sjögren's syndrome-like disease in mice with T cells lacking class 1A phosphoinositide-3-kinase
JS Oak, JA Deane, MG Kharas, J Luo, TE Lane, LC Cantley, DA Fruman |
Proceedings of the National Academy of Sciences | 2006 |
Increase of B cell-activating factor of the TNF family (BAFF) after rituximab treatment: insights into a new regulating system of BAFF production
F Lavie, C Miceli-Richard, M Ittah, J Sellam, JE Gottenberg, X Mariette |
Annals of the rheumatic diseases | 2006 |
A role for BLyS in the activation of innate immune cells
SK Chang, BK Arendt, JR Darce, X Wu, DF Jelinek |
Blood | 2006 |
B cell-activating factor of the tumor necrosis factor family (BAFF) is expressed under stimulation by interferon in salivary gland epithelial cells in primary Sjögren's syndrome
M Ittah, C Miceli-Richard, JE Gottenberg, F Lavie, T Lazure, N Ba, J Sellam, C Lepajolec, X Mariette |
Arthritis Research & Therapy | 2006 |
No evidence for an association between the -871 T/C promoter polymorphism in the B-cell-activating factor gene and primary Sjögren's syndrome
JE Gottenberg, J Sellam, M Ittah, F Lavie, A Proust, H Zouali, C Sordet, J Sibilia, RP Kimberly, X Mariette, C Miceli-Richard |
Arthritis Research & Therapy | 2006 |
A soluble BAFF antagonist, BR3-Fc, decreases peripheral blood B cells and lymphoid tissue marginal zone and follicular B cells in cynomolgus monkeys
Y Vugmeyster, D Seshasayee, W Chang, A Storn, K Howell, S Sa, T Nelson, F Martin, I Grewal, E Gilkerson, B Wu, J Thompson, BN Ehrenfels, S Ren, A Song, TR Gelzleichter, DM Danilenko |
The American Journal of Pathology | 2006 |
Sjögren-Syndrom: Aktuelle Aspekte aus rheumatologischer Sicht
C Tomiak, T Dörner |
Zeitschrift für Rheumatologie | 2006 |
Selective activation of TACI by syndecan-2
D Bischof, SF Elsawa, G Mantchev, J Yoon, GE Michels, A Nilson, SL Sutor, JL Platt, SM Ansell, G von Bulow, RJ Bram |
Blood | 2006 |
Unexpected development of autoimmunity in BAFF-R-mutant MRL-lpr mice.
Ju ZL, Shi GY, Zuo JX, Zhang JW |
Immunology | 2006 |
Lymphoma and other malignancies in primary Sjögren's syndrome.
Pillemer SR |
Annals of the rheumatic diseases | 2006 |
BLyS and APRIL in Rheumatoid Arthritis
Thorsten M. Seyler, Yong W. Park, Seisuke Takemura, Richard J. Bram, Paul J. Kurtin, Jörg J. Goronzy, Cornelia M. Weyand |
Journal of Clinical Investigation | 2005 |
Impaired early B cell tolerance in patients with rheumatoid arthritis
J Samuels, YS Ng, C Coupillaud, D Paget, E Meffre |
Journal of Experimental Medicine | 2005 |
A fundamental bimodal role for neuropeptide Y1 receptor in the immune system
J Wheway, CR Mackay, RA Newton, A Sainsbury, D Boey, H Herzog, F Mackay |
Journal of Experimental Medicine | 2005 |
Long term remission of Sjögren's syndrome associated aggressive B cell non-Hodgkin's lymphomas following combined B cell depletion therapy and CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone)
M Voulgarelis, S Giannouli, AG Tzioufas, HM Moutsopoulos |
Annals of the rheumatic diseases | 2005 |
Identification and characterization of circulating human transitional B cells
GP Sims, R Ettinger, Y Shirota, CH Yarboro, GG Illei, PE Lipsky |
Blood | 2005 |
Association Between Circulating Levels of the Novel TNF Family Members APRIL and BAFF and Lymphoid Organization in Primary Sjögren’s Syndrome
MV Jonsson, P Szodoray, S Jellestad, R Jonsson, K Skarstein |
Journal of Clinical Immunology | 2005 |
Successful treatment of a patient with primary Sjögren's syndrome with Rituximab
T Ring, M Kallenbach, J Prætorius, S Nielsen, B Melgaard |
Clinical Rheumatology | 2005 |
Inhibitory oligodeoxynucleotides – therapeutic promise for systemic autoimmune diseases?
P Lenert |
Clinical & Experimental Immunology | 2005 |
Comparative analysis of signal transduction by CD40 and the Epstein-Barr virus oncoprotein LMP1 in vivo
D Panagopoulos, P Victoratos, M Alexiou, G Kollias, G Mosialos |
Journal of virology | 2004 |
Aromatase-deficient mice spontaneously develop a lymphoproliferative autoimmune disease resembling Sjogren's syndrome
GJ Shim, M Warner, HJ Kim, S Andersson, L Liu, J Ekman, O Imamov, ME Jones, ER Simpson, JA Gustafsson |
Proceedings of the National Academy of Sciences | 2004 |
Raised levels of anti-glucose-6-phosphate isomerase IgG in serum and synovial fluid from patients with inflammatory arthritis
M Schaller, W Stohl, SM Tan, VM Benoit, DM Hilbert, HJ Ditzel |
Annals of the rheumatic diseases | 2004 |
The current status of targeting BAFF/BLyS for autoimmune diseases
M Ramanujam, A Davidson |
Arthritis Research & Therapy | 2004 |
Ageing, autoimmunity and arthritis: senescence of the B cell compartment - implications for humoral immunity
SA Johnson, JC Cambier |
Arthritis Research & Therapy | 2004 |
APRIL-deficient mice have normal immune system development
E Varfolomeev, F Kischkel, F Martin, D Seshasayee, H Wang, D Lawrence, C Olsson, L Tom, S Erickson, D French, P Schow, IS Grewal, A Ashkenazi |
Molecular and cellular biology | 2004 |
Programmed Cell Death of Peripheral Blood B Cells Determined by Laser Scanning Cytometry in Sj�gren?s Syndrome with a Special Emphasis on BAFF
P Szodoray, S Jellestad, P Alex, T Zhou, PC Wilson, M Centola, JG Brun, R Jonsson |
Journal of Clinical Immunology | 2004 |
BAFF selectively enhances the survival of plasmablasts generated from human memory B cells
Danielle T. Avery, Susan L. Kalled, Julia I. Ellyard, Christine Ambrose, Sarah A. Bixler, Marilyn Thien, Robert Brink, Fabienne Mackay, Philip D. Hodgkin, Stuart G. Tangye |
Journal of Clinical Investigation | 2003 |
Targeting B cells for the treatment of rheumatoid arthritis
TJ Oligino, SA Dalrymple |
Arthritis Research & Therapy | 2003 |
Use of localised gene transfer to develop new treatment strategies for the salivary component of Sjögren's syndrome
MR Kok, BJ Baum, PP Tak, SR Pillemer |
Annals of the rheumatic diseases | 2003 |
SLE--systemic lupus erythematosus: a BLySful, yet BAFFling, disorder
W Stohl |
Arthritis Research & Therapy | 2003 |
B cell receptor-independent stimuli trigger immunoglobulin (Ig) class switch recombination and production of IgG autoantibodies by anergic self-reactive B cells
TG Phan, M Amesbury, S Gardam, J Crosbie, J Hasbold, PD Hodgkin, A Basten, R Brink |
Journal of Experimental Medicine | 2003 |
G-CSF-stimulated neutrophils are a prominent source of functional BLyS
P Scapini, B Nardelli, G Nadali, F Calzetti, G Pizzolo, C Montecucco, MA Cassatella |
Journal of Experimental Medicine | 2003 |
The level of BLyS (BAFF) correlates with the titre of autoantibodies in human Sjögren's syndrome
X Mariette, S Roux, J Zhang, D Bengoufa, F Lavie, T Zhou, R Kimberly |
Annals of the rheumatic diseases | 2003 |
Recent advances in understanding molecular mechanisms in the pathogenesis and antibody profile of Sjögren’s syndrome
R Jonsson, TP Gordon, YT Konttinen |
Current Rheumatology Reports | 2003 |
Manipulation of Lymphoid Microenvironments in Non-Human Primates by an Inhibitor of the Lymphotoxin Pathway
Jennifer L. Gommerman, Fabienne Mackay, Elina Donskoy, Werner Meier, Pauline Martin, Jeffrey L. Browning |
Journal of Clinical Investigation | 2002 |
The buzz about BAFF
David Vaux |
Journal of Clinical Investigation | 2002 |
Sjögren's syndrome criteria
R Manthorpe |
Annals of the rheumatic diseases | 2002 |
Abnormalities of B cell phenotype, immunoglobulin gene expression and the emergence of autoimmunity in Sjögren's syndrome.
Dörner T, Lipsky PE |
Arthritis research | 2002 |